GLP-1 RA and SGLT2i: New Treatment Strategies for Diabetes and Obesity in the Context of HIV

Todd T. Brown, MD, PhD
Professor of Medicine and Epidemiology
Division of Endocrinology, Diabetes, and Metabolism
Johns Hopkins University, Baltimore, MD

Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2024. All rights reserved.



VIDEOTop of page

PRN no longer offers CME or ABIM MOC.Top of page

About the Presenter:Top of page

Todd Brown is the primary endocrine consultant to the Johns Hopkins HIV Clinic. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in HIV-infected patients. He is the co-chair of the Executive Committee of the MACS WIHS Combined Cohort Study and has served in leadership positions for the ACTG. He has mentored multiple trainees from across the country and around the world in the area of HIV Comorbidities and Aging. He has published widely on the topic of HIV and endocrine conditions and lectures internationally on this and other issues related to metabolic diseases in HIV.

Learning Objectives: Top of page

At the completion of this educational activity learners will:
1. Be able to describe how GLP-1 receptor agonists and SGLT2 inhibitors work
2. Know the risks and benefits of GLP-1 receptor agonists and SGLT2 inhibitors and where they fit in for the treatment of diabetes.
3. Understand the impact of GLP-1 receptor agonists for the treatment of obesity and be familiar with unanswered questions about their long-term safety and efficacy
4. Understand what is known about these medications in people with HIV.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. Joseph P. McGowan (Moderator) has no relevant financial relationships to disclose.
- Dr. Todd T. Brown (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to Merck, ViiV and Janssen. Dr. Brown supported his presentation and clinical recommendations with the best available evidence from the medical literature, and submitted his slides in advance for adequate peer review. All relevant financial relationships have been mitigated.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from Gilead Sciences and ViiV Healthcare.

You must be logged in to post a comment. Login | Register